The effect of COVID 19 on liver enzymes: A field study on the patients of Al-Kindi hospital in Baghdad

Recent studies have related to COVID 19 is a virus that spread in China at the end of 2019 and its first target is the respiratory system and spreads to the rest of the body, and its symptoms range from mild to severe, Where liver enzymes are evaluated in the laboratory to see what differences they will have. In this study, included 120 patients infected with COVID 19 who were confirmed to have a PCR test. As well as the other group called the control group was selected and they were not infected with the virus, as it was confirmed that they were not infected with a PCR test, the hospital's approval was obtained, as well as the patients. As result, we can imply that the results were compared between the group of patients and the control group, and it was found that liver enzymes rise in the case of infection with the virus. As ALP and AST increased in most patients, which is considered statistically significant while ALT increased in almost a third of patients, and the lowest test was the bilirubin, which increased in 10% Almost from patients, on the contrary, albumin decreased in two thirds of patients. While all examinations were normal in the control group. Where the risk of severe symptoms of COVID-19 increases in the elderly, as there is a role for age and some accompanying diseases such as diabetes, pressure, liver and kidney diseases, a role in the rise of these enzymes.